Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

Reviewed Reviewed
May 15 2010

Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that the Company has adjourned today's Special Meeting of Shareholders (the "Special Meeting") to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.

The Company's proxy materials previously filed with the Securities and Exchange Commission (the "SEC") on February 23, 2010 and the proposals being submitted to a vote of the shareholders at the Special Meeting as described in such proxy materials remain unchanged. The Company encourages those shareholders that held shares as of February 19, 2010, the record date of the Special Meeting, to vote their shares on the proposals.  

Source:

Cell Therapeutics, Inc.

Posted in:

Tags: , , , , , , , ,

Comments (0)

Suggested Reading

Waters launches new walk-up solutions that further simplify the analysis of biologic drug product and cell culture media
Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education
Stuart Orkin receives the third Elaine Redding Brinster Prize for development of sickle cell disease therapy
Single-cell screening of cerebral organoids to identify developmental defects in autism
ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients
Shorter telomere length of leucocytes may signal heightened dementia risk
Innovations in baculovirus–insect cell expression systems
Wireless molecular-electrical communications for tumor-cell-induced apoptosis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »
You might also like...
Study sheds light on the cause of craniosynostosis in infants